Blocking of the CD44 gene via RNA interference (RNAi) was reported to significantly inhibit ovarian cancer cell growth and tumour blood vessel formation and reduce disease recurrence and metastasis [107]. This evidence concerns the gene CD44 and ovarian cancer.